WD09C4J |
cis-1-(4-Ethylcyclohexyl)ethyl acetate |
63573-95-5 |
Detail |
WD09C4K |
trans-1-(4-Ethylcyclohexyl)ethyl acetate |
63573-94-4 |
Detail |
WD09C4L |
cis-alpha,4-Dimethylcyclohexylmethyl acetate |
63573-89-7 |
Detail |
WD09C4M |
trans-alpha,4-Dimethylcyclohexylmethyl acetate |
63573-88-6 |
Detail |
WD09C4N |
alpha-Propylcyclohexylmethyl acetate |
63573-84-2 |
Detail |
WD09C4O |
N-[4-[[2-[4-[(butylsulfonyl)amino]phenoxy]-1-oxotetradecyl]amino]-5-chloro-2-hydroxyphenyl]benzamide |
63573-38-6 |
Detail |
WD09C4P |
L-Tyrosine,O-[(3-bromophenyl)methyl]-N-[(1,1-dimethylethoxy)carbonyl]-3,5-diiodo- |
63570-43-4 |
Detail |
WD09C4Q |
Benzenecarboximidamide,N-hydroxy-4-(hydroxymethyl)- |
635702-23-7 |
Detail |
WD09C4R |
Merck SIP Agonist |
635701-59-6 |
Detail |
WD09C4S |
Methyl (16alpha,1beta,19alpha)-17-methoxy-19-methyloxayohimban-16-carboxylate |
63569-19-7 |
Detail |